NFIL3 and cancer: To test this hypothesis, we exogenously overexpressed NFIL3 driven by CMV enhancer in two TNBC cell lines (Fig. 1H) and an additional seven cancer cell lines representing six cancer types (Supplementary Fig. 1H-I) and detected the impact of elevated NFIL3 protein on the transcription of the endogenous NFIL3 gene.